Detalhe da pesquisa
1.
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer.
Cancer Immunol Res
; 10(6): 680-697, 2022 06 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35446942
2.
Breast cancer prevention by short-term inhibition of TGFß signaling.
Nat Commun
; 13(1): 7558, 2022 12 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36476730
3.
Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System.
Mol Cancer Res
; 19(4): 623-635, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33443130
4.
Immune Escape during Breast Tumor Progression.
Cancer Immunol Res
; 8(4): 422-427, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32238387
5.
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.
Nat Commun
; 10(1): 4182, 2019 09 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31519911
6.
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 4: 10, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29761158
7.
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
Cancer Discov
; 7(10): 1098-1115, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28652380
8.
Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma.
Mol Cancer Res
; 14(10): 928-940, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27358111
9.
Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma.
Clin Cancer Res
; 20(5): 1235-48, 2014 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24366691